NEW YORK--(BUSINESS WIRE)--Chembio Diagnostics, Inc. (OTCBB:CEMI) has reported its financial results for the third quarter ended September 30, 2006. Revenues for the third quarter of 2006 were $1.02 million, an 8% increase over third quarter 2005 revenues of $945,000. The third quarter 2006 net loss attributable to common stockholders was $2.33 million, or $0.21 per share, compared with a net loss attributable to common stockholders of $1.04 million, or $0.13 per share, for the third quarter of 2005.
